These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 7062992)
1. Epidemiologic features of chronic atrial fibrillation: the Framingham study. Kannel WB; Abbott RD; Savage DD; McNamara PM N Engl J Med; 1982 Apr; 306(17):1018-22. PubMed ID: 7062992 [TBL] [Abstract][Full Text] [Related]
2. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Benjamin EJ; Levy D; Vaziri SM; D'Agostino RB; Belanger AJ; Wolf PA JAMA; 1994 Mar; 271(11):840-4. PubMed ID: 8114238 [TBL] [Abstract][Full Text] [Related]
3. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Kannel WB; Wolf PA; Benjamin EJ; Levy D Am J Cardiol; 1998 Oct; 82(8A):2N-9N. PubMed ID: 9809895 [TBL] [Abstract][Full Text] [Related]
4. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Lloyd-Jones DM; Wang TJ; Leip EP; Larson MG; Levy D; Vasan RS; D'Agostino RB; Massaro JM; Beiser A; Wolf PA; Benjamin EJ Circulation; 2004 Aug; 110(9):1042-6. PubMed ID: 15313941 [TBL] [Abstract][Full Text] [Related]
6. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Benjamin EJ; Wolf PA; D'Agostino RB; Silbershatz H; Kannel WB; Levy D Circulation; 1998 Sep; 98(10):946-52. PubMed ID: 9737513 [TBL] [Abstract][Full Text] [Related]
7. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up]. Guize L; Thomas F; Bean K; Benetos A; Pannier B Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434 [TBL] [Abstract][Full Text] [Related]
8. Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study. Truelsen T; Lindenstrøm E; Boysen G Stroke; 1994 Apr; 25(4):802-7. PubMed ID: 8160224 [TBL] [Abstract][Full Text] [Related]
9. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. Wilhelmsen L; Rosengren A; Lappas G J Intern Med; 2001 Nov; 250(5):382-9. PubMed ID: 11887972 [TBL] [Abstract][Full Text] [Related]
10. [Impact of chronic atrial fibrillation on cardiovacular mortality]. Scardi S; Mazzone C Ital Heart J Suppl; 2000 Sep; 1(9):1117-22. PubMed ID: 11140280 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703 [TBL] [Abstract][Full Text] [Related]
12. Preventing stroke in people with atrial fibrillation: a cross-sectional study. de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708 [TBL] [Abstract][Full Text] [Related]
13. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Vaziri SM; Larson MG; Benjamin EJ; Levy D Circulation; 1994 Feb; 89(2):724-30. PubMed ID: 8313561 [TBL] [Abstract][Full Text] [Related]
14. Coronary heart disease and atrial fibrillation: the Framingham Study. Kannel WB; Abbott RD; Savage DD; McNamara PM Am Heart J; 1983 Aug; 106(2):389-96. PubMed ID: 6869222 [No Abstract] [Full Text] [Related]
15. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307 [TBL] [Abstract][Full Text] [Related]
16. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Stewart S; Hart CL; Hole DJ; McMurray JJ Am J Med; 2002 Oct; 113(5):359-64. PubMed ID: 12401529 [TBL] [Abstract][Full Text] [Related]
17. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. Staerk L; Wang B; Preis SR; Larson MG; Lubitz SA; Ellinor PT; McManus DD; Ko D; Weng LC; Lunetta KL; Frost L; Benjamin EJ; Trinquart L BMJ; 2018 Apr; 361():k1453. PubMed ID: 29699974 [TBL] [Abstract][Full Text] [Related]
18. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Krahn AD; Manfreda J; Tate RB; Mathewson FA; Cuddy TE Am J Med; 1995 May; 98(5):476-84. PubMed ID: 7733127 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study. Berge T; Lyngbakken MN; Ihle-Hansen H; Brynildsen J; Pervez MO; Aagaard EN; Vigen T; Kvisvik B; Christophersen IE; Steine K; Omland T; Smith P; Røsjø H; Tveit A BMJ Open; 2018 Aug; 8(7):e021704. PubMed ID: 30068617 [TBL] [Abstract][Full Text] [Related]
20. [Frequency and predictors of atrial fibrillation in severe mitral regurgitation]. Duran NE; Duran I; Sönmez K; Gençbay M; Akçay A; Turan F Anadolu Kardiyol Derg; 2003 Jun; 3(2):129-34. PubMed ID: 12826507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]